SLC39A9 and prostate cancer: In this regard, ZIP9 has been found highly expressed and bound by androgen hormones in ovarian, breast and prostate cancer cells [15], and testosterone has been demonstrated to increase intracellular Zn2+ levels in the same hormone-sensitive tumors, where it led to high Zn2+ concentration-mediated apoptosis [12,16].